Journal of Vascular Medicine & Surgery

Ventricular Arrhythmia: Types, Causes, Symptoms and Treatment Techniques

Zhang Qian^* Department of Cardiology, Nanjing Medical University, Jiangsu, China
^*Correspondence: Zhang Qian, Department of Cardiology, Nanjing Medical University, Jiangsu, China, Email:

Received: 01-Oct-2023, Manuscript No. JVMS-23-23919; Editor assigned: 03-Oct-2023, Pre QC No. JVMS-23-23919 (PQ); Reviewed: 17-Oct-2023, QC No. JVMS-23-23919; Revised: 24-Oct-2023, Manuscript No. JVMS-23-23919 (R); Published: 03-Nov-2023, DOI: 10.35248/2329-6925.23.S18.526

Description

Ventricular arrhythmias are an example of potentially fatal abnormal cardiac rhythm that originates in the lower chambers of the heart. These arrhythmias can damage the regular cardiac circulation function, resulting in major impacts such as sudden cardiac arrest [1,2].

Types of ventricular arrhythmias

Ventricular arrhythmias encompass a wide range of conditions, each characterized by different patterns of abnormal electrical activity in the ventricles:

Ventricular Tachycardia (VT): VT is a regular rhythm that starts in the ventricles, typically with a rate exceeding 100 beats per minute. This rapid rhythm can reduce the heart's ability to pump blood effectively and may cause dizziness, chest pain, or in severe cases, sudden cardiac arrest.

Ventricular Fibrillation (VF): VF is a chaotic and disorganized electrical activity in the ventricles, causing the heart to move rather than circulate blood. It is a medical emergency and it can result in sudden cardiac arrest.

Torsades de pointes: This is a unique form of ventricular tachycardia characterized by a different transforming pattern on an Electrocardiogram (ECG). It is frequently associated with a prolonged QT interval and can lead to fainting or VF [3,4].

Causes of ventricular arrhythmias

Understanding the fundamental causes of ventricular arrhythmias is essential for effective diagnosis and management. Common causes include:

Structural heart disease: Conditions such as coronary artery disease, heart attacks (myocardial infarctions), cardiomyopathy, and heart valve disorders can create an environment conducive to ventricular arrhythmias.

Previous heart surgery: Scars or altered electrical pathways resulting from cardiac surgery can increase the risk of ventricular arrhythmias.

Electrical conduction abnormalities: Abnormalities in the electrical conduction system of the heart, including prolonged QT syndrome and Brugada syndrome, can contribute individuals to ventricular arrhythmias.

Ischemia: A lack of oxygen supply to the heart muscle, this occurs in myocardial ischemia or acute coronary syndromes can trigger ventricular arrhythmias.

Electrolyte imbalances: Disturbances in blood electrolyte levels, particularly potassium and magnesium, can disrupt the heart's electrical activity.

Medications: Some medications, such as certain antiarrhythmics, antibiotics, and psychotropic drugs, can prolong the QT interval and increase the risk of ventricular arrhythmias.

Hypothermia: Severe body temperature reduction, frequently observed in death or cold exposure situations, can induce ventricular arrhythmias [5,6].

Symptoms of ventricular arrhythmias

Ventricular arrhythmias can emerge with a wide range of symptoms, depending on their type and severity. Common symptoms include:

Palpitations: A sensation of rapid or irregular heartbeats.

Dizziness or lightheadedness: Frequently accompanied by a feeling of impending fainting.

Chest pain: Angina-like discomfort may be experienced, especially in cases of sustained ventricular tachycardia.

Shortness of breath: In severe cases, breathing difficulties may arise due to decreased blood flow to the body.

Loss of consciousness: Syncope (fainting) can occur suddenly and may be a sign of a life-threatening arrhythmia.

Treatment options

The treatment of ventricular arrhythmias aims to manage symptoms, prevent life-threatening events, and address underlying causes. Techniques may include:

Medications: Antiarrhythmic drugs are prescribed to control ventricular arrhythmias, including beta-blockers, sodium channel blockers, and amiodarone [7-10].

Implantable Cardioverter-Defibrillator (ICD): For patients at high risk of sudden cardiac arrest, an ICD is implanted to monitor heart rhythm and deliver electric shocks (defibrillation) if life-threatening arrhythmias, such as ventricular Fibrillation.

Catheter ablation: In some cases of drug-resistant or recurrent ventricular arrhythmias, a catheter ablation procedure may be performed to destroy abnormal electrical pathways within the heart.

Lifestyle modifications: Lifestyle changes, such as avoiding triggers such as excessive alcohol or caffeine and managing stress, can help to reduce the risk of arrhythmias.

Treatment of underlying conditions: If ventricular arrhythmias are secondary to other heart conditions, addressing the underlying problem, such as coronary artery disease or cardiomyopathy, is essential.

Genetic testing: When ventricular arrhythmias are caused by hereditary disorders, genetic testing for the patient and their family members may be indicated.

Emergency treatment: Immediate treatment with defibrillation and advanced life support measures is essential in cases of sudden cardiac arrest caused by ventricular fibrillation.

References

1. Podrid PJ, Fogel RI, Fuchs TT. Ventricular arrhythmia in congestive heart failure. Am J Cardiol. 1992;69(18):82-96.

   [Crossref] [Google Scholar] [PubMed]

2. Kuo CS, Munakata K, Reddy CP, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circ. 1983;67(6):1356-1367.

   [Crossref] [Google Scholar] [PubMed]

3. Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circ. 2002;106(14):1800-1805.

   [Crossref] [Google Scholar] [PubMed]

4. Hennessy S, Leonard CE, Newcomb C, Kimmel SE, Bilker WB. Cisapride and ventricular arrhythmia. Br J Clin Pharmacol. 2008;66(3):375-385.

   [Crossref] [Google Scholar] [PubMed]

5. McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med. 1987;317(13):787-792.

   [Crossref] [Google Scholar] [PubMed]

6. Podrid PJ, Fuchs T, Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circ. 1990;82(2 Suppl):I103-I113.

   [Google Scholar] [PubMed]

7. Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, Wu TJ, et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circ. 2000;101(16):1960-1969.

   [Crossref] [Google Scholar] [PubMed]

8. St John Sutton M, Lee D, Rouleau JL, Goldman S, Plappert T, Braunwald E, et al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circ. 2003;107(20):2577-2582.

   [Crossref] [Google Scholar] [PubMed]

9. Dresen WF, Ferguson JD. Ventricular arrhythmias. Cardiology clinics. 2018;36(1):129-139.
10. John RM, Tedrow UB, Koplan BA, Albert CM, Epstein LM, Sweeney MO, et al. Ventricular arrhythmias and sudden cardiac death. Lancet. 2012;380(9852):1520-1529.

    [Google Scholar]